Quantitative Sensory Testing Does Not Predict Chronic Pain Syndromes: Large Study from TwinsUK
Amber Rhee, Author; Isabelle Granville Smith, Author; Roger Compte, Author; Jelle Vehof, Author; Ayrun Nessa, Author; Samuel Wadge, Author; Maxim Freidin, Author; Frances Williams, Author
Synopsis
Unlike in neuropathic and nociceptive pain, literature on the validity of quantitative sensory testing (QST) in nociplastic pain is inconclusive. We examined whether diagnoses of chronic pain syndromes (CPS) were associated with QST modalities in a large, population study of 3,033 participants. CPS have been described as primarily nociplastic and, in our sample, included chronic widespread pain, irritable bowel syndrome, dry eye disease, and migraine. Mann-Whitney U tests revealed no differences in QST test scores between cases and controls across ten different QST modalities. The inability of QST to discriminate between cases and controls calls for caution in its use in assigning diagnostic categories and prognosis in primarily nociplastic pain.
Disclosures
Nothing to Disclose by any Author
Author(s):
Sacroplasty Using a Steerable Osteotome: Technical Note and Case Series
Amber Valeri, DO, Author; Nam Tran, MD, Author
Utilizing a steerable, curved osteotome, sacroplasty can be safely and successfully utilized to improve pain for oncology patients.
Author(s):
Spinal Cord Stimulation for Painful Neuropathy: Special Considerations in Brittle Diabetes
Daniel Adams, PA-C, MSHS, Author; Morgan Mingo, NP, Author; Bethany Pontius, NP, Author; Nicole Souza, Author; Claire Hubert, MS-3, Author; Kanchen Loganathan, DO, Author; Dr. Dmitri Souza, MD, PhD, Author
Synopsis
There is ample evidence to support the use of spinal cord stimulation in the treatment of refractory painful diabetic neuropathy.[1, 2] Adverse effects of spinal cord stimulator implant have been well documented and include the risks of lead migration, infection, spinal cord injury, intolerance, and others.[3] However, there have been few reports of diabetic ketoacidosis following this intervention.
Disclosures
Nothing to Disclose by any Author
Author(s):
Efficacy of Kyphoplasty alone versus Kyphoplasty and Radiofrequency Ablation on Osteoblastic Lesions in Breast Cancer patients: A Single-center 10-year experience
Christine Mau, MD, Author; Vishni Iyer, BS, Author; Nam Tran, MD, PhD, Author
Synopsis
Evaluation of the largest series of patients with osteoblastic lesions treated with kyphoplasty versus kyphoplasty and radiofrequency ablation to assess clinical efficacy based on pain, functional status, and pain medication use.
Disclosures
Nothing to Disclose by any Author
Author(s):
Improved psychological symptoms predicted improved pain interference and pain locations after online multidisciplinary pain treatment
David Talavera, PhD, Author; Corinne Cooley, DPT, Author; Allie Van Nuys, OTD, Author; Dokyoung Sophia You, PhD, Author; Heather Poupore-King, PhD, Author
Synopsis
Multidisciplinary pain treatment is effective treatment for chronic pain (You et al., 2021). Since the COVID-19 outbreak, telemedicine has been rapidly adapted and the traditional, in-person multidisciplinary pain programs have been reformatted and adjusted for online programs (Ziadni et al., 2021). However, the effectiveness of the online multidisciplinary pain program and its mechanisms of change remain unknown (Buhrman et al., 2016). Early evidence suggests that the online program may be less effective. To examine its effect and potential mechanisms of change, the current study examined the patient-reported outcomes (PROs) of a zoom-delivered, interactive multidisciplinary pain program, which consisted of psychologists-lead Cognitive Behavioral Therapy (CBT) and physical or occupational therapists-led movement (“CBT and Movement”) programs.
Disclosures
Nothing to Disclose by any Author
Author(s):